SUMO conjugating enzyme Ubc9

spinqualitylabelsall models SUMO conjugating enzyme Ubc9 tetramer 2gjd Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Function SUMO conjugating enzyme Ubc9 accepts the ubiquitin-like SUMOs and catalyzes their attachment to other proteins with the help of E3 ligase. Relevance Ubc9 inhibitors may be therapeutic agents against fibrotic diseases like rheumatoid arthritis.

3D Structures of SUMO conjugating enzyme Ubc9

Updated on 10-December-2023

{"openlevels":0}

• Ubc9
  • 1a3s - hUbc9 - human
    
  • 5f6e – hUbc9 (mutant)
    
  • 1u9a - mUbc9 - mouse
    
  • 1u9b - mUbc9 (mutant)
    
  • 2gjd – yUbc9 - yeast
    
  • 4jue, 4m1n – Ubc9 – Plasmodium falciparum
    
• Ubc9 complexes
  • 2xwu – hUbc9+importin13
    
  • 2px9 – hUbc9+SUMO2
    
  • 2pe6, 8odr - hUbc9+SUMO1
    
  • 4y1l – hUbc9 + RSUME
    
  • 6q83 – hUbc9 + KAP122
    
  • 6syf – hUbc9 + peptide
    
  • 5f6d, 5f6u, 5f6v, 5f6w, 5f6x, 5f6y – hUbc9 (mutant) + inhibitor
    
  • 2o25, 2px9 - hUbc9+ ubiquitin-conjugating enzyme E1
    
  • 2grn - hUbc9+ RAN GTPase activating protein 1 C-terminal
    
  • 1kps - hUbc9+ RAN GTPase activating protein 1
    
  • 1z5s - hUbc9+ RAN GTPase activating protein 1 C-terminal+SMT3C+RAN-binding protein 2
    
  • 3uin, 3uio, 3uip - hUbc9+ RAN GTPase activating protein 1 + SUMO2 + RANBP2
    
  • 4w5v, 5fq2 - hUbc9+ SUMO activating enzyme
    
  • 5d2m - hUbc9+ RAN GTPase activating protein 1 + SUMO2 + ZNF451
    
  • 2gro, 2grp, 2grq, 2grr - hUbc9 (mutant)+ RAN GTPase activating protein 1 C-terminal
    
  • 3a4s – hUbc9 + NFATC2-interacting protein ubiquitin-like domain
    
  • 2vrr, 2uyz – mUbc9+SUMO1
    
  • 3ong, 3onh – yUbc9+ubiquitin-conjugating enzyme E1-like
    
  • 2eke – yUbc9+SMT3
    
  • 5jne – yUbc9 + SMT3 + PCNA + SIZ1
    
  • 7p47 – yUbc9 + SMT3 + MMS21 + SMC5
    
  • 3rcz – Ubc9 + DNA repair protein SUMO-like domain – fission yeast
    

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel, Joel L. Sussman